|
|||||
|
|
Acute and chronic administration of SHRl17887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models |
|
| Authors: | Xiao LIU Li-na ZHANG Ying FENG Lei ZHANG Hui QU Guo-qing CAO Ying LENG |
| Affiliation: | [1]State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203,China [2]Shanghai Hengrui Pharmaceuticals Co, Ltd, Shanghai 201203, China |
| Abstract: | |
| Keywords: | SHR117887 vildagliptin （LAF237） dipeptidyl peptidase-4 （DPP-4） type 2 diabetes mellitus glucagon-like peptide-1 （GLP-1） insulin β-cells |
| 本文献已被 维普 等数据库收录！ | |